No Data
No Data
BofA Securities Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $109
Gilead Sciences: Durable Growth and Attractive Valuation Justify Buy Rating
The Zacks Analyst Blog Uber, Comcast, Gilead Sciences and Onfolio Holdings
Earnings Week Ahead: MCD, KO, CSCO, PARA, MRNA, ROKU, SMCI, CVS, SHOP and More
Unusual Options Activity: VG, MCHP and Others Attract Market Bets, VG V/OI Ratio Reaches 227.3
EST Feb 6th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
U.S. stock market digging gold | Cathie Wood and Pelosi's favorite stock Tempus AI surged nearly 12% overnight, doubling in price this year; Google's capital expenditure far exceeded expectations, benefiting stock Celestica rose nearly 9%, reaching a hist
Sister Wood is betting on the AI pharmaceutical revolution, and "Pelosi's favorite stock" Tempus AI surged nearly 12% overnight, doubling its stock price this year; Google's capital expenditures this year far exceeded expectations, benefiting Celestica, which rose nearly 9% and reached a historic high in stock price.